ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IBRX ImmunityBio, Inc.

已收盘 11-05 16:00:00 EST

8.01

-0.92

-10.30%

盘后8.06

+0.05+0.62%

19:59 EST

最高8.79	最低8.00	成交量1,256万
今开8.78	昨收8.93	日振幅8.85%
总市值84.89亿	流通市值32.60亿	总股本10.60亿
成交额1.04亿	换手率3.09%	流通股本4.07亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IBRX","market":"US","secType":"STK","nameCN":"ImmunityBio, Inc.","latestPrice":8.01,"timestamp":1793912400000,"preClose":8.93,"halted":0,"volume":12556460,"hourTrading":{"tag":"盘后","latestPrice":8.06,"preClose":8.01,"latestTime":"19:59 EST","volume":181999,"amount":1456964.9736,"timestamp":1793926774949,"change":0.05,"changeRate":0.006242,"amplitude":0.019675},"delay":0,"changeRate":-0.10302351623740201,"floatShares":407000000,"shares":1059836273,"eps":-0.988661,"marketStatus":"已收盘","change":-0.92,"latestTime":"11-05 16:00:00 EST","open":8.78,"high":8.79,"low":8,"amount":103581076.29996,"amplitude":0.088466,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.988661,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1793955600000},"marketStatusCode":5,"adr":0,"listingDate":1438056000000,"exchange":"NASDAQ","adjPreClose":8.93,"preHourTrading":{"tag":"盘前","latestPrice":8.79,"preClose":8.93,"latestTime":"09:29 EST","volume":22300,"amount":196656.6086,"timestamp":1793888999999,"change":-0.14,"changeRate":-0.015677,"amplitude":0.027861},"postHourTrading":{"tag":"盘后","latestPrice":8.06,"preClose":8.01,"latestTime":"19:59 EST","volume":181999,"amount":1456964.9736,"timestamp":1793926774949,"change":0.05,"changeRate":0.006242,"amplitude":0.019675},"volumeRatio":1.526028,"impliedVol":1.2081,"impliedVolPercentile":0.6892},"requestUrl":"/m/hq/s/IBRX","defaultTab":"news","newsList":[{"id":"1191547180","title":"异动解读｜ImmunityBio, Inc.盘中下跌5.26%，欧洲首批Anktiva患者完成用药","url":"https://stock-news.laohu8.com/highlight/detail?id=1191547180","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191547180?lang=zh_cn&edition=full","pubTime":"2026-11-05 22:58","pubTimestamp":1793890701,"startTime":"0","endTime":"0","summary":"11月5日，ImmunityBio, Inc.盘中下跌5.26%，报8.4642美元／股，成交额1123.72万美元。消息面上，公司此前宣布欧洲首批患者已接受Anktiva联合疗法，用于治疗对BCG无应答的非肌层浸润性膀胱癌伴原位癌患者，这一进展成为近期股价波动的核心事件。该里程碑发生在Anktiva于2月获得欧盟有条件上市许可之后。公司称，Accord Healthcare提供商业支持，Uniphar负责供应链服务，以推动Anktiva在欧洲市场的可及性，显示其欧洲商业化落地继续推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Anktiva欧洲启动首批用药，股价盘中走低","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154352267","title":"异动解读｜ImmunityBio盘中上涨5.31%，欧洲首批Anktiva患者完成用药","url":"https://stock-news.laohu8.com/highlight/detail?id=1154352267","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154352267?lang=zh_cn&edition=full","pubTime":"2026-11-05 04:29","pubTimestamp":1793824141,"startTime":"0","endTime":"0","summary":"11月5日，ImmunityBio盘中上涨5.31%，报8.73美元／股，成交额5289.3万美元。消息面上，公司宣布欧洲首批患者已接受Anktiva联合疗法，用于治疗对BCG无应答的非肌层浸润性膀胱癌伴原位癌患者，这成为股价异动的直接催化。该进展发生在Anktiva于2月获得欧盟有条件上市许可之后。公司表示，Accord Healthcare提供商业支持，Uniphar负责供应链服务，以推动该药在欧洲市场的可及性，显示其欧洲商业化落地正进一步推进。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"ImmunityBio拉升，欧洲首批患者完成Anktiva治疗","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193362258","title":"异动解读｜ImmunityBio盘中上涨5.03%，报8.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193362258","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193362258?lang=zh_cn&edition=full","pubTime":"2026-11-03 22:52","pubTimestamp":1793717573,"startTime":"0","endTime":"0","summary":"11月3日，ImmunityBio盘中上涨5.03%，报8.35美元/股，成交额819.57万美元。ImmunityBio所在的生物科技行业中，Moderna, Inc.上涨4.64%，Natera, Inc.上涨3.73%，福泰制药下跌1.41%，吉利德科学上涨0.27%，神经分泌生物科学上涨12.98%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189426533","title":"异动解读｜ImmunityBio盘中下跌5.15%，报8.244美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1189426533","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189426533?lang=zh_cn&edition=full","pubTime":"2026-10-30 22:20","pubTimestamp":1793370010,"startTime":"0","endTime":"0","summary":"10月30日，ImmunityBio盘中下跌5.15%，报8.244美元／股，成交额1750.21万美元。ImmunityBio所在的生物科技行业中，再生元制药公司涨11.88%，Moderna, Inc.跌2.02%，艾伯维公司涨1.1%，吉利德科学涨3.79%，福泰制药涨2.04%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195523567","title":"异动解读｜ImmunityBio盘中上涨5.06%，报8.205美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195523567","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195523567?lang=zh_cn&edition=full","pubTime":"2026-10-27 21:52","pubTimestamp":1793109177,"startTime":"0","endTime":"0","summary":"10月27日，ImmunityBio盘中上涨5.06%，报8.205美元/股，成交额1016.65万美元。ImmunityBio所在的生物科技行业中，Moderna, Inc.跌7.88%，艾伯维公司跌0.19%，安进跌0.01%，Argenx SE跌0.56%，吉利德科学跌0.94%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196966660","title":"异动解读｜ImmunityBio盘中下跌5.17%，报7.795美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1196966660","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196966660?lang=zh_cn&edition=full","pubTime":"2026-10-26 22:06","pubTimestamp":1793023609,"startTime":"0","endTime":"0","summary":"10月26日，ImmunityBio盘中下跌5.17%，报7.795美元／股，成交额1569.1万美元。ImmunityBio所在的生物科技行业中，Moderna, Inc.涨0.14%，安进涨2.29%，Xencor Inc涨20.45%，艾伯维公司涨1.06%，Genmab A/S涨2.22%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122466416","title":"异动解读｜ImmunityBio盘中下跌5.44%，报8.135美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122466416","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122466416?lang=zh_cn&edition=full","pubTime":"2026-10-23 00:50","pubTimestamp":1792687802,"startTime":"0","endTime":"0","summary":"10月23日，ImmunityBio盘中下跌5.44%，报8.135美元／股，成交额4969.64万美元。ImmunityBio所在的生物科技行业中，Moderna, Inc.跌19.69%，艾伯维公司跌0.57%，安进涨1.96%，Argenx SE跌1.82%，吉利德科学涨0.95%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149810835","title":"异动解读｜ImmunityBio盘中下跌5.03%，报8.3292美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149810835","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149810835?lang=zh_cn&edition=full","pubTime":"2026-10-22 00:36","pubTimestamp":1792600609,"startTime":"0","endTime":"0","summary":"10月22日，ImmunityBio盘中下跌5.03%，报8.3292美元／股，成交额4910.35万美元。ImmunityBio所在的生物科技行业中，Moderna, Inc.涨2.43%，艾伯维公司跌2.22%，吉利德科学跌2.38%，Roivant Sciences Ltd.涨4.17%，福泰制药涨0.17%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117704286","title":"异动解读｜ImmunityBio盘中上涨5.23%，报8.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117704286","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117704286?lang=zh_cn&edition=full","pubTime":"2026-10-21 00:32","pubTimestamp":1792513970,"startTime":"0","endTime":"0","summary":"10月21日，ImmunityBio盘中上涨5.23%，报8.86美元／股，成交额5842.1万美元。ImmunityBio所在的生物科技行业中，Moderna, Inc.涨4.05%，艾伯维公司涨2.27%，吉利德科学涨1.5%，安进涨2.23%，Argenx SE涨6.28%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115607871","title":"异动解读｜ImmunityBio盘中下跌5.45%，报8.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115607871","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115607871?lang=zh_cn&edition=full","pubTime":"2026-10-19 22:03","pubTimestamp":1792418583,"startTime":"0","endTime":"0","summary":"10月19日，ImmunityBio盘中下跌5.45%，报8.68美元／股，成交额3493.45万美元。ImmunityBio所在的生物科技行业中，Moderna, Inc.涨2.22%，Silence Therapeutics Plc涨125.52%，Disc Medicine涨32.61%，艾伯维公司涨0.01%，安进涨0.05%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123947747","title":"异动解读｜ImmunityBio盘中下跌5.75%，报9.429美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1123947747","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123947747?lang=zh_cn&edition=full","pubTime":"2026-10-16 21:50","pubTimestamp":1792158648,"startTime":"0","endTime":"0","summary":"10月16日，ImmunityBio盘中下跌5.75%，报9.429美元／股，成交额1957.72万美元。ImmunityBio所在的生物科技行业中，Moderna, Inc.跌5.9%，艾伯维公司涨0.34%，安进涨0.5%，吉利德科学跌0.6%，福泰制药跌0.09%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162104923","title":"异动解读｜ImmunityBio盘中上涨5.6%，Anktiva中东获批与商业化进展提振预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1162104923","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162104923?lang=zh_cn&edition=full","pubTime":"2026-10-15 22:18","pubTimestamp":1792073894,"startTime":"0","endTime":"0","summary":"10月15日，ImmunityBio盘中上涨5.6%，报10.425美元／股，成交额6338.72万美元。消息面上，公司核心产品Anktiva在中东市场的准入与商业化推进，成为股价异动的重要支撑。已披露信息显示，Anktiva于7月获得阿联酋对特定膀胱癌及转移性非小细胞肺癌适应症的上市许可，更早前已在沙特阿拉伯上市。叠加公司二季度营收同比升至5120万美元，显示其产品放量与海外拓展仍在延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ImmunityBio上扬，Anktiva中东获批加速商业化","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180315710","title":"异动解读｜ImmunityBio盘中上涨5.05%，Anktiva中东获批与商业化进展提振预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1180315710","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180315710?lang=zh_cn&edition=full","pubTime":"2026-10-15 01:04","pubTimestamp":1791997497,"startTime":"0","endTime":"0","summary":"10月15日，ImmunityBio盘中上涨5.05%，报10.295美元/股，成交额1.46亿美元。消息面上，公司核心产品Anktiva此前相继取得中东市场准入进展，成为股价异动的重要支撑。已披露信息显示，Anktiva于7月获得阿联酋对特定膀胱癌及转移性非小细胞肺癌适应症的上市许可；更早前，该产品已在沙特阿拉伯上市。叠加公司二季度营收同比升至5120万美元，显示其商业化推进仍在延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ImmunityBio股价上涨，Anktiva中东获批催化","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155169029","title":"异动解读｜ImmunityBio盘中下跌5.24%，报9.5906美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1155169029","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155169029?lang=zh_cn&edition=full","pubTime":"2026-10-13 21:52","pubTimestamp":1791899574,"startTime":"0","endTime":"0","summary":"10月13日，ImmunityBio盘中下跌5.24%，报9.5906美元／股，成交额1964.4万美元。ImmunityBio所在的生物科技行业中，Moderna, Inc.跌2.83%，Alaunos Therapeutics涨63.33%，艾伯维公司跌0.97%，Scinai Immunotherapeutics Ltd.涨47.41%，安进跌0.64%。ImmunityBio是一家领先的晚期免疫治疗公司，可激活先天和适应性免疫系统，以治疗肿瘤学和传染病领域内严重未满足的需求。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139865238","title":"异动解读｜ImmunityBio盘中上涨5.05%，生物科技板块整体走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1139865238","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139865238?lang=zh_cn&edition=full","pubTime":"2026-10-09 22:01","pubTimestamp":1791554461,"startTime":"0","endTime":"0","summary":"10月9日，ImmunityBio盘中上涨5.05%，报10.41美元/股，成交额1653.98万美元。ImmunityBio所在的生物科技行业中，整体表现偏强，个股中Moderna涨9.77%，Twist Bioscience涨6.79%，艾伯维公司涨1.08%，吉利德科学涨1.47%，安进涨0.87%。ImmunityBio是一家领先的晚期免疫治疗公司，专注于激活先天和适应性免疫系统以治疗肿瘤学和传染病领域严重未满足的需求，拥有自然杀伤细胞疗法、抗体细胞因子融合蛋白及疫苗载体等综合平台。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190673867","title":"异动解读｜ImmunityBio盘中下跌5.15%，生物科技板块整体走弱","url":"https://stock-news.laohu8.com/highlight/detail?id=1190673867","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190673867?lang=zh_cn&edition=full","pubTime":"2026-10-06 22:12","pubTimestamp":1791295974,"startTime":"0","endTime":"0","summary":"10月6日，ImmunityBio盘中下跌5.15%，报9.8448美元/股，成交额3439.29万美元。ImmunityBio所在的生物科技行业中，个股整体表现偏弱，其中Moderna跌6.16%，Twist Bioscience跌5.20%，Natera跌6.09%，Vaxcyte跌11.45%，安进跌1.19%。ImmunityBio是一家领先的晚期免疫治疗公司，专注于激活先天和适应性免疫系统以治疗肿瘤学和传染病领域严重未满足的需求，拥有自然杀伤细胞疗法、抗体细胞因子融合蛋白及疫苗载体等综合平台。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118820937","title":"异动解读｜ImmunityBio盘前上涨5.69%，报10.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1118820937","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118820937?lang=zh_cn&edition=full","pubTime":"2026-10-05 21:11","pubTimestamp":1791205861,"startTime":"0","endTime":"0","summary":"10月5日，ImmunityBio盘前上涨5.69%，报10.86美元/股，成交额459.19万美元。ImmunityBio所在的生物科技行业中，整体表现偏弱，个股中Moderna跌0.14%，艾伯维公司跌0.08%，安进跌0.76%，Natera跌0.38%，吉利德科学涨0.18%。ImmunityBio是一家领先的晚期免疫治疗公司，专注于激活先天和适应性免疫系统以治疗肿瘤学和传染病领域内严重未满足的需求，拥有自然杀伤细胞疗法、抗体细胞因子融合蛋白及疫苗载体等综合平台。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129590799","title":"异动解读｜ImmunityBio盘中上涨10.13%，报10.2527美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1129590799","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129590799?lang=zh_cn&edition=full","pubTime":"2026-10-02 21:54","pubTimestamp":1790949290,"startTime":"0","endTime":"0","summary":"10月2日，ImmunityBio盘中上涨10.13%，报10.2527美元/股，成交额4092.69万美元。ImmunityBio所在的生物科技行业中，个股整体表现偏弱，其中Moderna跌0.29%，安进跌0.52%，吉利德科学跌0.93%，艾伯维公司跌0.24%，Natera跌0.16%。ImmunityBio是一家晚期免疫治疗公司，专注于激活先天和适应性免疫系统以治疗肿瘤学和传染病领域严重未满足的需求，拥有自然杀伤细胞疗法、抗体细胞因子融合蛋白及疫苗载体等综合平台。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114267783","title":"PDS生物技术宣布完成至多2230万美元的PIPE融资首轮交割，并任命Patrick Soon-Shiong博士为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1114267783","media":"美股速递","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114267783?lang=zh_cn&edition=full","pubTime":"2026-09-14 22:31","pubTimestamp":1789396270,"startTime":"0","endTime":"0","summary":"PDS生物技术公司今日正式宣布，已成功完成高达2230万美元的PIPE融资的首次交割。与此同时，该公司还披露了一项重大人事变动——任命Patrick Soon-Shiong博士加入其董事会。PDS生物技术公司作为一家专注于开发癌症免疫疗法的临床阶段生物制药企业，此次融资的成功交割，标志着公司在推进其创新疗法研发管线的道路上迈出了坚实的一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRX","PDSB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148284703","title":"前世界银行行长金墉博士加盟ImmunityBio，出任副董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=1148284703","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148284703?lang=zh_cn&edition=full","pubTime":"2026-08-10 21:01","pubTimestamp":1786366871,"startTime":"0","endTime":"0","summary":"ImmunityBio宣布，已任命前世界银行行长、全球卫生领域领军人物金墉博士（DR. Jim Yong Kim）为副董事长。这位医卫界翘楚的加入，将为这家生物科技公司注入新的战略视野。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunitybio.com","stockEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":-0.1397},{"period":"3month","weight":0.2199},{"period":"6month","weight":0.0494},{"period":"1year","weight":3.2933},{"period":"ytd","weight":3.5101}],"compareEarnings":[{"period":"1week","weight":-0.0071},{"period":"1month","weight":-0.0104},{"period":"3month","weight":-0.0023},{"period":"6month","weight":0.0396},{"period":"1year","weight":0.1356},{"period":"ytd","weight":0.1245}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ImmunityBio, Inc.于2002年10月7日在伊利诺伊州ZelleRx Corporation公司的名义下注册成立，于2010年1月22日，公司更名为Conkwest股份有限公司。ImmunityBio是一家领先的晚期免疫治疗公司，可激活先天和适应性免疫系统，以治疗肿瘤学和传染病领域内严重未满足的需求。公司是一家领先的临床剂型的现成自然杀伤细胞疗法生产商，记忆NK细胞，连同抗体细胞因子融合蛋白、白蛋白结合化学免疫调节剂和疫苗载体的综合平台。通过结合这些NK、巨噬细胞和T细胞激活平台，该公司相信ImmunityBio在免疫治疗领域处于领先地位，具有跨越多种肿瘤类型和传染病的后期临床开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.219152},{"month":2,"riseRate":0.545455,"avgChangeRate":0.075725},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.095867},{"month":4,"riseRate":0.454545,"avgChangeRate":0.012919},{"month":5,"riseRate":0.454545,"avgChangeRate":0.054516},{"month":6,"riseRate":0.363636,"avgChangeRate":0.135253},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.043039},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.09189},{"month":9,"riseRate":0.416667,"avgChangeRate":-0.015071},{"month":10,"riseRate":0.416667,"avgChangeRate":0.01725},{"month":11,"riseRate":0.666667,"avgChangeRate":0.118144},{"month":12,"riseRate":0.363636,"avgChangeRate":0.048951}],"exchange":"NASDAQ","name":"ImmunityBio, Inc.","nameEN":"ImmunityBio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ImmunityBio, Inc.(IBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ImmunityBio, Inc.,IBRX,ImmunityBio, Inc.股票,ImmunityBio, Inc.股票老虎,ImmunityBio, Inc.股票老虎国际,ImmunityBio, Inc.行情,ImmunityBio, Inc.股票行情,ImmunityBio, Inc.股价,ImmunityBio, Inc.股市,ImmunityBio, Inc.股票价格,ImmunityBio, Inc.股票交易,ImmunityBio, Inc.股票购买,ImmunityBio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ImmunityBio, Inc.(IBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}